Extended-interval dosing of natalizumab in NOVA

被引：0
|
作者：
Stuve, Olaf [1 ,2 ]
Tugemann, Bastian
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Peter O Donnell Jr Brain Inst, Dallas, TX USA
[2] VA North Texas Hlth Care Syst Dallas, Dallas, TX 75216 USA
来源：
LANCET NEUROLOGY | 2023年 / 22卷 / 03期
关键词：
D O I：
10.1016/s1474-4422(23)00032-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [11] Extended-Interval Dosing of Aminoglycosides in Pediatrics: A Narrative Review
    Salehifar, Ebrahim
    Rafati, Mohammad Reza
    [J]. JOURNAL OF PEDIATRICS REVIEW, 2015, 3 (02)
  • [12] Pharmacodynamics of natalizumab extended interval dosing in MS
    Zhovtis Ryerson, Lana
    Li, Xiaochun
    Goldberg, Judith D.
    Hoyt, Tamara
    Christensen, Angel
    Metzger, Ryan R.
    Kister, Ilya
    Foley, John
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (02):
  • [13] Efficacy and safety of natalizumab extended interval dosing
    Zeineddine, M.
    Ayyoubi, N.
    Tamim, H.
    Nicolas, J.
    Khoury, S.
    Yamout, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 871 - 871
  • [14] Extended interval dosing of natalizumab: is efficacy preserved?
    Clerico, M.
    Signori, A.
    De Mercanti, S.
    Cordioli, C.
    Signoriello, E.
    Lus, G.
    Maniscalco, G. T.
    Curti, E.
    Lorefice, L.
    Cocco, E.
    Nociti, V.
    Mirabella, M.
    Baroncini, D.
    Landi, D.
    Mataluni, G.
    Petruzzo, M.
    Lanzillo, R.
    Gandoglia, I.
    Laroni, A.
    Frangiamore, R.
    Sartori, A.
    Cavalla, P.
    Costantini, G.
    Sormani, M. P.
    Capra, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 282 - 283
  • [15] Extended interval dosing of natalizumab in multiple sclerosis
    Ryerson, L. Zhovtis
    Frohman, T. C.
    Foley, J.
    Kister, I.
    Weinstock-Guttman, B.
    Tornatore, C.
    Pandey, K.
    Donnelly, S.
    Pawate, S.
    Bomprezzi, R.
    Smith, D.
    Kolb, C.
    Qureshi, S.
    Okuda, D.
    Kalina, J.
    Rimler, Z.
    Green, R.
    Monson, N.
    Hoyt, T.
    Bradshaw, M.
    Fallon, J.
    Chamot, E.
    Bucello, M.
    Beh, S.
    Cutter, G.
    Major, E.
    Herbert, J.
    Frohman, E. M.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (08): : 885 - 889
  • [16] Efficacy and safety of natalizumab extended interval dosing
    Yamout, Bassem, I
    Sahraian, Mohamad Ali
    El Ayoubi, Nabil
    Tamim, Hani
    Nicolas, Johnny
    Khoury, Samia J.
    Zeineddine, Maya M.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 24 : 113 - 116
  • [17] Efficacy and safety of natalizumab extended interval dosing
    Zeineddine, Maya
    Ayyoubi, Nabil
    Tamim, Hani
    Nicolas, Johny
    Khoury, Samia
    Yamout, Bassem
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP22 - NP23
  • [18] Modeling the Efficacy of Natalizumab in Multiple Sclerosis Patients Who Switch From Every-4-Week Dosing to Extended-Interval Dosing
    Chang, Ih
    Muralidharan, Kumar Kandadi
    Campbell, Nolan
    Ho, Pei-Ran
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (03): : 339 - 348
  • [19] Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis
    Graham, AC
    Mercier, RC
    Achusim, LE
    Pai, MP
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (06) : 936 - 941
  • [20] Extended interval dosing of natalizumab: More evidence in support
    Toljan, Karlo
    Conway, Devon S.
    [J]. NEUROTHERAPEUTICS, 2024, 21 (03)
12345